EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Knockdown of ketohexokinase versus inhibition of its kinase activity exert divergent effects on fructose metabolism

Se-Hyung Park, Taghreed Fadhul, Lindsey R Conroy, Harrison A Clarke, Ramon C Sun, Kristina Wallenius, Jeremie Boucher, Gavin O'Mahony, Alessandro Boianelli, Marie Persson, Sunhee Jung, Cholsoon Jang und 7 weitere

JCI Insight · 06.12.2024 · 9 (23)

DOI: 10.1172/jci.insight.184396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, online erschienen am 06.12.2024. Verfasst von Se-Hyung Park und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Division of Pediatric Gastroenterology and. Hauptthemen laut MEDLINE: Fructokinases, Fructose, Hepatocytes. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIGMS NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Excessive fructose intake is a risk factor for the development of obesity and its complications. Targeting ketohexokinase (KHK), the first enzyme of fructose metabolism, has been investigated for the management of metabolic dysfunction–associated steatotic liver disease (MASLD). We compared the effects of systemic, small molecule inhibitor of KHK enzymatic activity with hepatocyte-specific, N-acetylgalactosamine siRNA–mediated knockdown of KHK in mice on an HFD. We measured KHK enzymatic activity, extensively quantified glycogen accumulation, performed RNA-Seq analysis, and enumerated hepatic metabolites using mass spectrometry. Both KHK siRNA and KHK inhibitor led to an improvement in liver steatosis; however, via substantially different mechanisms, KHK knockdown decreased the de novo lipogenesis pathway, whereas the inhibitor increased the fatty acid oxidation pathway. Moreover, KHK knockdown completely prevented hepatic fructolysis and improved glucose tolerance. Conversely, the KHK inhibitor only partially reduced fructolysis, but it also targeted triokinase, mediating the third step of fructolysis. This led to the accumulation of fructose-1 phosphate, resulting in glycogen accumulation, hepatomegaly, and impaired glucose tolerance. Overexpression of wild-type, but not kinase-dead, KHK in cultured hepatocytes increased hepatocyte injury and glycogen accumulation after treatment with fructose. The differences between KHK inhibition and knockdown are, in part, explained by the kinase-dependent and -independent effects of KHK on hepatic metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FructokinasesFructoseHepatocytesAnimalsMiceMaleLiverGene Knockdown TechniquesMice, Inbred C57BLRNA, Small InterferingHumansLipogenesisDisease Models, Animal

Stichwörter der Autor:innen

Carbohydrate metabolismHepatitisHepatologyMetabolismObesity

Substanzen

ketohexokinaseFructokinasesFructoseRNA, Small Interfering

Autor:innen und Institutionen

  • Department of Pediatrics and Division of Pediatric Gastroenterology and.
  • Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, Kentucky, USA.
  • Department of Biochemistry & Molecular Biology, Center for Advanced Spatial Biomolecule Research, University of Florida, Gainesville, Florida, USA.
  • Bioscience, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Medicinal Chemistry and.

Förderung

  • NICHD NIH HHS
  • NIGMS NIH HHS
  • NIDDK NIH HHS
  • NASPGHAN Foundation Young Investigator Award
  • Pediatric Scientist Development Program Award
  • University of Kentucky

Zitieren

APA

Park, S. H., Fadhul, T., Conroy, L. R., Clarke, H. A., Sun, R. C., Wallenius, K., Boucher, J., O'Mahony, G., Boianelli, A., Persson, M., Jung, S., Jang, C., Loria, A. S., Martinez, G. J., Kipp, Z. A., Bates, E. A., Hinds, T. D., Divanovic, S., & Softic, S. (2024). Knockdown of ketohexokinase versus inhibition of its kinase activity exert divergent effects on fructose metabolism. JCI Insight, 9(23). https://doi.org/10.1172/jci.insight.184396

Vancouver

Park SH, Fadhul T, Conroy LR, Clarke HA, Sun RC, Wallenius K, et al. Knockdown of ketohexokinase versus inhibition of its kinase activity exert divergent effects on fructose metabolism. JCI Insight. 2024;9(23). doi:10.1172/jci.insight.184396

BibTeX
@article{Park2024,
  author = {Park, Se-Hyung and Fadhul, Taghreed and Conroy, Lindsey R and Clarke, Harrison A and Sun, Ramon C and Wallenius, Kristina and Boucher, Jeremie and O'Mahony, Gavin and Boianelli, Alessandro and Persson, Marie and Jung, Sunhee and Jang, Cholsoon and Loria, Analia S and Martinez, Genesee J and Kipp, Zachary A and Bates, Evelyn A and Hinds, Terry D and Divanovic, Senad and Softic, Samir},
  title = {Knockdown of ketohexokinase versus inhibition of its kinase activity exert divergent effects on fructose metabolism},
  journal = {JCI Insight},
  year = {2024},
  volume = {9},
  number = {23},
  doi = {10.1172/jci.insight.184396}
}
Kostenlos starten →